BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36448466)

  • 1. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
    Escaron AL; Garcia J; Petrik AF; Ruiz E; Nyongesa DB; Thompson JH; Coronado GD
    J Prim Care Community Health; 2022; 13():21501319221138423. PubMed ID: 36448466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.
    Bharti B; May FFP; Nodora J; Martínez ME; Moyano K; Davis SL; Ramers CB; Garcia-Bigley F; O'Connell S; Ronan K; Barajas M; Gordon S; Diaz G; Ceja E; Powers M; Arredondo EM; Gupta S
    Cancer; 2019 Dec; 125(23):4203-4209. PubMed ID: 31479529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equitable Implementation of Mailed Stool Test-Based Colorectal Cancer Screening and Patient Navigation in a Safety Net Health System.
    Scott RE; Chang P; Kluz N; Baykal-Caglar E; Agrawal D; Pignone M
    J Gen Intern Med; 2023 May; 38(7):1631-1637. PubMed ID: 36456842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics.
    Petrik AF; Keast E; Johnson ES; Smith DH; Coronado GD
    BMC Health Serv Res; 2020 Nov; 20(1):1028. PubMed ID: 33172444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program.
    Green BB; Baldwin LM; West II; Schwartz M; Coronado GD
    J Prim Care Community Health; 2020; 11():2150132720958525. PubMed ID: 32912056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process.
    Coronado GD; Kihn-Stang A; Slaughter MT; Petrik AF; Thompson JH; Rivelli JS; Jimenez R; Gibbs J; Yadav N; Mummadi RR
    BMC Gastroenterol; 2021 Sep; 21(1):356. PubMed ID: 34583638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Colorectal Cancer Test Follow-Up: A Quality Improvement Initiative at a Federally Qualified Health Center.
    Shareef F; Bharti B; Garcia-Bigley F; Hernandez M; Nodora J; Liu J; Ramers C; Nery JD; Marquez J; Moyano K; Rojas S; Arredondo E; Gupta S
    J Prim Care Community Health; 2024; 15():21501319241242571. PubMed ID: 38554066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.
    Oluloro A; Petrik AF; Turner A; Kapka T; Rivelli J; Carney PA; Saha S; Coronado GD
    J Community Health; 2016 Aug; 41(4):864-70. PubMed ID: 26874943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.
    Issaka RB; Singh MH; Oshima SM; Laleau VJ; Rachocki CD; Chen EH; Day LW; Sarkar U; Somsouk M
    Am J Gastroenterol; 2017 Feb; 112(2):375-382. PubMed ID: 28154400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program.
    Green BB; West II; Baldwin LM; Schwartz MR; Coury J; Coronado GD
    J Community Health; 2020 Oct; 45(5):916-921. PubMed ID: 32219712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers associated with inadequate follow-up of abnormal fecal immunochemical test results in a safety-net system: A mixed-methods analysis.
    Issaka RB; Bell-Brown A; Kao J; Snyder C; Atkins DL; Chew LD; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    Prev Med Rep; 2022 Aug; 28():101831. PubMed ID: 35637893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving colorectal cancer screening in rural primary care: Preliminary effectiveness and implementation of a collaborative mailed fecal immunochemical test pilot.
    Davis MM; Coury J; Larson JH; Gunn R; Towey EG; Ketelhut A; Patzel M; Ramsey K; Coronado GD
    J Rural Health; 2023 Jan; 39(1):279-290. PubMed ID: 35703582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45-49-year-old community health center population.
    O'Leary MC; Reuland DS; Correa SY; Moore AA; Malo TL; Tan X; Rohweder CL; Wheeler SB; Brenner AT
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):125-133. PubMed ID: 37300632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
    Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
    Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial.
    Coronado GD; Leo MC; Ramsey K; Coury J; Petrik AF; Patzel M; Kenzie ES; Thompson JH; Brodt E; Mummadi R; Elder N; Davis MM
    Implement Sci Commun; 2022 Apr; 3(1):42. PubMed ID: 35418107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.
    Cusumano VT; Corona E; Partida D; Yang L; Yu C; May FP
    BMC Gastroenterol; 2020 Apr; 20(1):115. PubMed ID: 32306919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing barriers to colorectal cancer screening in a federally qualified health center.
    Centra T; Fogg C
    J Am Assoc Nurse Pract; 2023 Jul; 35(7):415-424. PubMed ID: 36745041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Two Evidence-Based Intervention Strategies to Promote CRC Screening Among Latino Adults in a Primary Care Setting.
    Castañeda SF; Bharti B; Espinoza-Giacinto RA; Sanchez V; O'Connell S; Muñoz F; Mercado S; Meza ME; Rojas W; Talavera GA; Gupta S
    J Racial Ethn Health Disparities; 2018 Jun; 5(3):530-535. PubMed ID: 28634873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.